Pharmaceutical Company – Attadale Partners

Challenge

We partnered with a pharmaceutical company that is a global enterprise with core competencies in the Life Science fields of healthcare and agriculture. Within the US healthcare system, screening rates of type 2 diabetics for early evidence of kidney disease remains unacceptably low. Today, within a standalone clinic, between 30-60% of type 2 diabetics are being screened annually. The pharmaceutical company wants to engage, activate, and motivate patients with type 2 diabetes (and potentially diabetic kidney disease) to ‘ask for the test’ (uACR) and ultimately ‘own’ an evidence-based screening program. While most patients know their cholesterol levels and last blood pressure, many don’t realize that uACR should be tested at the time of Type 2 DM diagnosis as well, as it is a potent risk marker for both cardiovascular disease as well as kidney disease progression.

Solution

Using our integrated platform, the pharmaceutical client easily gathered real-time insights about what is most important and how they choose between alternatives. Intuitive data visualization quickly led to decisions aligned with needs. We enabled the client to understand T2D patient and primary care physician perceptions about T2D, DKD, and uACR screenings.

Key Insights to Drive Actions

Results

The data showed that T2D patients have a low propensity for self-advocacy, instead trusting their primary care physicians to direct them to relevant T2D screenings and routine care. The data also showed that many physicians consider uACR to be a routine annual test for all T2D patients, and that there is a potential that physicians consider GFR screenings to be a superior early detection method over uACR. The client determined that their strategy of a campaign to stimulate patient-led self-advocacy for early detection via uACR would likely have significant barriers and have paused on making the investment into that intervention. They are currently in talks with the KHI to determine a best go-forward plan.

Challenge

Solution

Key Insights to Drive Actions

Results

Want to learn more?

Free ‘Global Real Estate Company’ case study